Status:

RECRUITING

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

Lead Sponsor:

BioMarin Pharmaceutical

Conditions:

Idiopathic Short Stature

Eligibility:

All Genders

3-11 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH)(hGH; only in the ...

Detailed Description

Following a minimum 6 month observational period in which baseline growth is assessed, participants in the vosoritide and placebo groups will complete a minimum of 6 months of randomized treatment (ma...

Eligibility Criteria

Key Inclusion Criteria:

  1. Height assessment corresponding to a height Z-score of ≤ -2.25 SDs in reference to the general population of the same age and sex, as calculated using the Centers for Disease Control and Prevention (CDC) growth charts
  2. Tanner Stage 1, at time of signing the ICF (unless too young to stage).

Key Exclusions:

  1. Known chromosomal imbalance or genetic variant causing short stature syndrome, including but not limited to Laron syndrome, Prader-Willi syndrome, Russell-Silver Syndrome, Turner syndrome, disproportionate skeletal dysplasias, abnormal SHOX gene analysis, or Rasopathy (including Noonan syndrome)
  2. Previous treatment with a growth promoting agent

Key Trial Info

Start Date :

October 21 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2036

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06382155

Start Date

October 21 2024

End Date

December 1 2036

Last Update

March 13 2026

Active Locations (47)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (47 locations)

1

Consano Clinical Research, LLC

California City, California, United States, 78231

2

Rady Children's Hospital - San Diego

California City, California, United States, 92123

3

Children's Hospital of Orange County Main Campus - Orange

California City, California, United States, 92868

4

Children's Hospital Los Angeles

Los Angeles, California, United States, 90027

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature | DecenTrialz